Handelsbanken Fonder’s Heron Therapeutics HRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-28,000
| Closed | -$160K | – | 1650 |
|
|
2022
Q1 | $160K | Hold |
28,000
| – | – | ﹤0.01% | 1655 |
|
|
2021
Q4 | $256K | Hold |
28,000
| – | – | ﹤0.01% | 1654 |
|
|
2021
Q3 | $299K | Hold |
28,000
| – | – | ﹤0.01% | 1592 |
|
|
2021
Q2 | $435K | Buy |
28,000
+6,300
| +29% | +$97.9K | ﹤0.01% | 1480 |
|
|
2021
Q1 | $352K | Buy |
21,700
+8,700
| +67% | +$141K | ﹤0.01% | 1380 |
|
|
2020
Q4 | $275K | Hold |
13,000
| – | – | ﹤0.01% | 1442 |
|
|
2020
Q3 | $193K | Hold |
13,000
| – | – | ﹤0.01% | 1393 |
|
|
2020
Q2 | $191K | Buy |
+13,000
| New | +$191K | ﹤0.01% | 1382 |
|